| Website | iscienceintervent... |
| Category | BioTech |
| Phone | 650.421.2700 |
| Employees | |
| Description | Glaucoma treatment devices |
| Series F, 5/09 Affinity Capital Management Johnson & Johnson Development L Capital Partners Prism VentureWorks Three Arch Partners De Novo Ventures Asset Management Company Clarian Health Ventures | $20.5M |
iScience Interventionalâ„¢ discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies.
This new category of therapy is called Interventional Ophthalmology. It encompasses microcatheter-based therapies designed to access a wide range of anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye.